|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5091513A
(en)
|
1987-05-21 |
1992-02-25 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
|
US5132405A
(en)
|
1987-05-21 |
1992-07-21 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
CA2026147C
(en)
|
1989-10-25 |
2006-02-07 |
Ravi J. Chari |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
US5061620A
(en)
|
1990-03-30 |
1991-10-29 |
Systemix, Inc. |
Human hematopoietic stem cell
|
|
US5151510A
(en)
|
1990-04-20 |
1992-09-29 |
Applied Biosystems, Inc. |
Method of synethesizing sulfurized oligonucleotide analogs
|
|
US6765087B1
(en)
|
1992-08-21 |
2004-07-20 |
Vrije Universiteit Brussel |
Immunoglobulins devoid of light chains
|
|
US6005079A
(en)
|
1992-08-21 |
1999-12-21 |
Vrije Universiteit Brussels |
Immunoglobulins devoid of light chains
|
|
ATE199392T1
(de)
|
1992-12-04 |
2001-03-15 |
Medical Res Council |
Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung
|
|
WO1994025591A1
(en)
|
1993-04-29 |
1994-11-10 |
Unilever N.V. |
PRODUCTION OF ANTIBODIES OR (FUNCTIONALIZED) FRAGMENTS THEREOF DERIVED FROM HEAVY CHAIN IMMUNOGLOBULINS OF $i(CAMELIDAE)
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
US7057017B2
(en)
|
1997-04-16 |
2006-06-06 |
Millennium Pharmaceuticals, Inc. |
Human dickkopf-related protein and nucleic acid molecules and uses therefor
|
|
JP4213224B2
(ja)
|
1997-05-02 |
2009-01-21 |
ジェネンテック，インコーポレーテッド |
ヘテロマルチマー及び共通成分を有する多重特異性抗体の製造方法
|
|
US6194551B1
(en)
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
|
US6528624B1
(en)
|
1998-04-02 |
2003-03-04 |
Genentech, Inc. |
Polypeptide variants
|
|
WO2001074164A1
(en)
|
2000-03-31 |
2001-10-11 |
The General Hospital Corporation |
Methods of modulating hair growth
|
|
US7713526B2
(en)
|
2001-05-01 |
2010-05-11 |
The Regents Of The University Of California |
Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
|
|
US20030044409A1
(en)
|
2001-05-01 |
2003-03-06 |
Carson Dennis A. |
Immunologic compositions and methods for studying and treating cancers expressing frizzled antigens
|
|
US7084257B2
(en)
|
2001-10-05 |
2006-08-01 |
Amgen Inc. |
Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
|
|
US7135174B2
(en)
|
2002-01-07 |
2006-11-14 |
Amgen Fremont, Inc. |
Antibodies directed to PDGFD and uses thereof
|
|
US7317091B2
(en)
|
2002-03-01 |
2008-01-08 |
Xencor, Inc. |
Optimized Fc variants
|
|
US7662925B2
(en)
|
2002-03-01 |
2010-02-16 |
Xencor, Inc. |
Optimized Fc variants and methods for their generation
|
|
US20040132101A1
(en)
|
2002-09-27 |
2004-07-08 |
Xencor |
Optimized Fc variants and methods for their generation
|
|
NZ537277A
(en)
|
2002-07-18 |
2008-04-30 |
Crucell Holland Bv |
Recombinant production of mixtures of antibodies
|
|
US7960512B2
(en)
|
2003-01-09 |
2011-06-14 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant Fc regions and methods of using same
|
|
JP2006524039A
(ja)
|
2003-01-09 |
2006-10-26 |
マクロジェニクス，インコーポレーテッド |
変異型Ｆｃ領域を含む抗体の同定および作製ならびにその利用法
|
|
US8461155B2
(en)
|
2003-09-22 |
2013-06-11 |
University Of Connecticut |
Sclerostin and the inhibition of WNT signaling and bone formation
|
|
US8367822B2
(en)
|
2003-09-22 |
2013-02-05 |
Enzo Therapeutics, Inc. |
Compositions and methods for bone formation and remodeling
|
|
US8637506B2
(en)
|
2003-09-22 |
2014-01-28 |
Enzo Biochem, Inc. |
Compositions and methods for bone formation and remodeling
|
|
US9046537B2
(en)
|
2003-09-22 |
2015-06-02 |
Enzo Biochem, Inc. |
Method for treating inflammation by administering a compound which binds LDL-receptor-related protein (LRP) ligand binding domain
|
|
WO2005032574A1
(en)
|
2003-10-03 |
2005-04-14 |
The Board Of Trustees Of The Leland Stanford Junior University |
Modulation of gastrointestinal epithelium proliferation through the wnt signaling pathway
|
|
CA2548817A1
(en)
|
2003-12-04 |
2005-06-23 |
Xencor, Inc. |
Methods of generating variant proteins with increased host string content and compositions thereof
|
|
AU2005214382B2
(en)
|
2004-02-19 |
2011-08-04 |
Genentech, Inc. |
CDR-repaired antibodies
|
|
WO2005119899A2
(en)
|
2004-05-13 |
2005-12-15 |
University Of Virginia Patent Foundation |
Use of lacritin in promoting ocular cell survival
|
|
US9052324B2
(en)
|
2004-05-19 |
2015-06-09 |
Enzo Biochem, Inc. |
Compounds and assays for controlling Wnt activity
|
|
US8343922B2
(en)
|
2004-05-19 |
2013-01-01 |
Enzo Biochem, Inc. |
Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells
|
|
PL1776384T3
(pl)
|
2004-08-04 |
2013-10-31 |
Mentrik Biotech Llc |
WARIANTY REGIONÓW Fc
|
|
MX2007001221A
(es)
|
2004-08-04 |
2007-03-23 |
Amgen Inc |
Anticuerpos para proteina dickkopf-1 (dkk-1).
|
|
DE102004050620A1
(de)
|
2004-10-13 |
2006-04-20 |
Eberhard-Karls-Universität Tübingen |
Monoklonaler Antikörper gegen Frizzled-Rezeptoren
|
|
US7462697B2
(en)
|
2004-11-08 |
2008-12-09 |
Epitomics, Inc. |
Methods for antibody engineering
|
|
EP1810035A4
(en)
|
2004-11-10 |
2010-03-17 |
Macrogenics Inc |
GENERATION OF FC ANTIBODY REGIONS FOR EFFECTOR FUNCTION
|
|
AU2005325801A1
(en)
|
2005-01-31 |
2006-08-03 |
Ablynx N.V. |
Method for generating variable domain sequences of heavy chain antibodies
|
|
CA2602663A1
(en)
|
2005-03-31 |
2006-10-05 |
Xencor, Inc. |
Fc variants with optimized properties
|
|
US7771937B2
(en)
|
2005-05-20 |
2010-08-10 |
University Of Washington |
Methods for predicting late onset Alzheimer disease in an individual
|
|
JP2008542366A
(ja)
|
2005-05-30 |
2008-11-27 |
アストラゼネカ・アクチエボラーグ |
Ｆｚｄ８モジュレーターを同定する方法および変形性関節症を処置するためのそのようなモジュレーターの使用
|
|
DE102005035568A1
(de)
|
2005-07-25 |
2007-02-01 |
M-Phasys Gmbh |
Frizzled 9 als Biomarker für Substrukturen des humanen Gehirns
|
|
US10155816B2
(en)
|
2005-11-28 |
2018-12-18 |
Genmab A/S |
Recombinant monovalent antibodies and methods for production thereof
|
|
CA2635906A1
(en)
|
2006-02-07 |
2007-08-16 |
Wyeth |
Materials and methods for identifying agents that modulate norrin. norrin mimetics, and agents identified thereby
|
|
WO2007146968A2
(en)
|
2006-06-12 |
2007-12-21 |
Trubion Pharmaceuticals, Inc. |
Single-chain multivalent binding proteins with effector function
|
|
CN101573383B
(zh)
|
2006-06-21 |
2015-05-13 |
肿瘤疗法科学股份有限公司 |
靶向肿瘤的针对卷曲同源物10的单克隆抗体及其用途
|
|
GB0624500D0
(en)
|
2006-12-07 |
2007-01-17 |
Istituto Superiore Di Sanito |
A novel passive vaccine for candida infections
|
|
JP2010515717A
(ja)
|
2007-01-11 |
2010-05-13 |
フィリップス−ウニベルジテート・マールブルク |
アルツハイマーおよび他の神経性認知症疾患の診断ならびに処置
|
|
WO2008134632A1
(en)
|
2007-04-26 |
2008-11-06 |
President And Fellows Of Harvard College |
Wnt ligands involved in blood-brain barrier development and uses therefor
|
|
KR20100091170A
(ko)
*
|
2007-11-02 |
2010-08-18 |
노파르티스 아게 |
저밀도-지단백질 수용체-관련 단백질 ６ (ｌｒｐ６)을 조정하기 위한 분자 및 방법
|
|
CA2705923A1
(en)
*
|
2007-11-16 |
2009-05-22 |
Nuvelo, Inc. |
Antibodies to lrp6
|
|
US9266967B2
(en)
|
2007-12-21 |
2016-02-23 |
Hoffmann-La Roche, Inc. |
Bivalent, bispecific antibodies
|
|
CN102065895A
(zh)
|
2008-04-11 |
2011-05-18 |
比奥根艾迪克Ma公司 |
抗-igf-1r抗体和其它化合物的治疗联合
|
|
WO2010016766A2
(en)
|
2008-08-08 |
2010-02-11 |
Koninklijke Nederlandse Akademie Van Wetenschappen |
Antibodies recognizing endogenous human lgr5 and/or lgr6
|
|
JP5685535B2
(ja)
|
2008-08-18 |
2015-03-18 |
ファイザー インコーポレイティッド |
Ｃｃｒ２に対する抗体
|
|
JP5859307B2
(ja)
|
2008-09-10 |
2016-02-10 |
ジェネンテック， インコーポレイテッド |
眼の血管新生を阻害する方法
|
|
CN103002911B
(zh)
|
2008-09-26 |
2015-08-26 |
昂考梅德药品有限公司 |
卷曲蛋白结合药剂及其应用
|
|
GB0819449D0
(en)
|
2008-10-23 |
2008-12-03 |
Cambridge Display Tech Ltd |
Display drivers
|
|
DK2356270T3
(da)
|
2008-11-07 |
2016-12-12 |
Fabrus Llc |
Kombinatoriske antistofbiblioteker og anvendelser deraf
|
|
EP2412800A1
(en)
|
2010-07-29 |
2012-02-01 |
Koninklijke Nederlandse Akademie van Wetenschappen |
Liver organoid, uses thereof and culture method for obtaining them
|
|
ES2579909T3
(es)
|
2009-02-03 |
2016-08-17 |
Koninklijke Nederlandse Akademie Van Wetenschappen |
Medio de cultivo para células madre epiteliales y organoides que comprenden dichas células madre
|
|
US20100254979A1
(en)
|
2009-03-06 |
2010-10-07 |
Cisthera, Incorporated |
Humanized PAI-1 Antibodies and Uses Thereof
|
|
JP2012525149A
(ja)
|
2009-04-27 |
2012-10-22 |
オンコメッド ファーマシューティカルズ インコーポレイテッド |
ヘテロ多量体分子を作製するための方法
|
|
AU2010298025B2
(en)
|
2009-09-25 |
2016-04-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Neutralizing antibodies to HIV-1 and their use
|
|
KR101268741B1
(ko)
|
2009-10-06 |
2013-06-04 |
김지연 |
줄기세포를 망막세포로 분화시키는 방법
|
|
CN102958942A
(zh)
|
2009-12-29 |
2013-03-06 |
新兴产品开发西雅图有限公司 |
异二聚体结合蛋白及其应用
|
|
US20140148348A1
(en)
|
2010-01-13 |
2014-05-29 |
Christine Kuslich |
Dectection of gastrointestinal disorders
|
|
US8859736B2
(en)
|
2010-02-19 |
2014-10-14 |
The Board Of Regents Of The University Of Oklahoma |
Monoclonal antibodies that inhibit the wnt signaling pathway and methods of production and use thereof
|
|
AR080795A1
(es)
|
2010-03-24 |
2012-05-09 |
Genentech Inc |
Anticuerpos anti-lrp6 (proteina relacionada con el receptor ldl tipo 6)
|
|
CA2794674A1
(en)
|
2010-04-01 |
2011-10-06 |
Oncomed Pharmaceuticals, Inc. |
Frizzled-binding agents and uses thereof
|
|
US20130274215A1
(en)
|
2010-04-08 |
2013-10-17 |
Fate Therapeutics, Inc. |
Pharmaceutical compositions to treat fibrosis
|
|
KR20130066631A
(ko)
|
2010-05-06 |
2013-06-20 |
노파르티스 아게 |
치료적 저밀도 지단백질-관련 단백질 ６ （ｌｒｐ６） 다가 항체에 대한 조성물 및 사용 방법
|
|
EP4234698A3
(en)
|
2010-05-06 |
2023-11-08 |
Novartis AG |
Compositions and methods of use for therapeutic low density lipoprotein-related protein 6 (lrp6) antibodies
|
|
PL2635607T3
(pl)
|
2010-11-05 |
2020-05-18 |
Zymeworks Inc. |
Projekt stabilnego przeciwciała heterodimerowego z mutacjami w domenie FC
|
|
JP2014506568A
(ja)
|
2011-01-28 |
2014-03-17 |
ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ |
Ｗｎｔ組成物およびその使用方法
|
|
GB201106395D0
(en)
|
2011-04-14 |
2011-06-01 |
Hubrecht Inst |
Compounds
|
|
EP2742067A4
(en)
|
2011-08-12 |
2015-03-04 |
Omeros Corp |
MONOCLONAL FZD10 ANTIBODIES AND METHOD FOR THEIR USE
|
|
AU2012308476B2
(en)
*
|
2011-09-16 |
2016-04-14 |
Fate Therapeutics, Inc. |
Wnt compositions and therapeutic uses of such compositions
|
|
CN109111523B
(zh)
|
2011-10-14 |
2022-06-07 |
诺华股份有限公司 |
用于Wnt途径相关疾病的抗体和方法
|
|
CN104039830A
(zh)
|
2011-11-04 |
2014-09-10 |
诺华股份有限公司 |
低密度脂蛋白相关蛋白6(lrp6)-半寿期延长物构建体
|
|
LT2794658T
(lt)
|
2011-12-19 |
2017-05-10 |
Synimmune Gmbh |
Bispecifinė antikūno molekulė
|
|
EP2804629A1
(en)
*
|
2012-01-18 |
2014-11-26 |
Genentech, Inc. |
Anti-lrp5 antibodies and methods of use
|
|
WO2014029752A1
(en)
|
2012-08-22 |
2014-02-27 |
Glaxo Group Limited |
Anti lrp6 antibodies
|
|
WO2014059068A1
(en)
|
2012-10-11 |
2014-04-17 |
The Trustees Of The University Of Pennsylvania |
Methods for the treatment and prevention of osteoporosis and bone-related disorders
|
|
WO2014059442A2
(en)
|
2012-10-12 |
2014-04-17 |
Arizona Board Agents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University |
Antibody based reagents that specifically recognize toxic oligomeric forms of tau
|
|
JP2016510411A
(ja)
|
2013-02-04 |
2016-04-07 |
オンコメッド ファーマシューティカルズ インコーポレイテッド |
Ｗｎｔ経路インヒビターによる処置の方法およびモニタリング
|
|
US10047163B2
(en)
|
2013-02-08 |
2018-08-14 |
Abbvie Stemcentrx Llc |
Multispecific constructs
|
|
CN105431161A
(zh)
|
2013-02-21 |
2016-03-23 |
范安德尔研究所 |
Norrin突变体多肽、其制造方法和用途
|
|
US20140255403A1
(en)
|
2013-03-06 |
2014-09-11 |
Hadasit Medical Research Services & Development Ltd. |
Oral composition comprising a tnf antagonist and use thereof
|
|
BR112015023074A2
(pt)
|
2013-03-14 |
2017-11-21 |
Oncomed Pharm Inc |
agentes de ligação-met e uso dos mesmos
|
|
US20160022769A1
(en)
|
2013-03-15 |
2016-01-28 |
Retinal Solutions Llc |
Compostions and methods for treating retinal disease
|
|
CA2906737C
(en)
|
2013-03-15 |
2023-08-15 |
Amgen Inc. |
Human pac1 antibodies
|
|
US9850297B2
(en)
|
2013-03-15 |
2017-12-26 |
Amgen Inc. |
Secreted frizzle-related protein 5 (SFRP5) binding proteins
|
|
EP3033356B1
(en)
|
2013-08-14 |
2020-01-15 |
Sachdev Sidhu |
Antibodies against frizzled proteins and methods of use thereof
|
|
GB2518221A
(en)
|
2013-09-16 |
2015-03-18 |
Sergej Michailovic Kiprijanov |
Tetravalent antigen-binding protein molecule
|
|
CA2922950A1
(en)
|
2013-09-30 |
2015-04-02 |
Shinya Ishii |
Method for producing antigen-binding molecule using modified helper phage
|
|
GB2519786A
(en)
|
2013-10-30 |
2015-05-06 |
Sergej Michailovic Kiprijanov |
Multivalent antigen-binding protein molecules
|
|
US9629801B2
(en)
|
2014-01-10 |
2017-04-25 |
Wisconsin Alumni Research Foundation |
Blood-brain barrier targeting antibodies
|
|
US9209965B2
(en)
|
2014-01-14 |
2015-12-08 |
Microsemi Semiconductor Ulc |
Network interface with clock recovery module on line card
|
|
WO2015109212A1
(en)
|
2014-01-17 |
2015-07-23 |
Pfizer Inc. |
Anti-il-2 antibodies and compositions and uses thereof
|
|
EP3177322A4
(en)
|
2014-08-08 |
2018-07-18 |
Alector LLC |
Anti-trem2 antibodies and methods of use thereof
|
|
WO2016037016A1
(en)
|
2014-09-03 |
2016-03-10 |
The Brigham And Women's Hospital, Inc. |
Compositions, systems, and methods for generating inner ear hair cells for treatment of hearing loss
|
|
US11142577B2
(en)
|
2014-09-12 |
2021-10-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
WNT signaling agonist molecules
|
|
SI3221357T1
(sl)
|
2014-11-20 |
2020-09-30 |
F. Hoffmann-La Roche Ag |
Pogoste lahke verige in načini uporabe
|
|
US9777052B2
(en)
|
2014-12-02 |
2017-10-03 |
The Board Of Regents Of The University Of Oklahoma |
R-spondin variants, compositions, and methods of use
|
|
CA2874083C
(en)
|
2014-12-05 |
2024-01-02 |
Universite Laval |
Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases
|
|
WO2016168607A1
(en)
|
2015-04-15 |
2016-10-20 |
University Of Tennessee Research Foundation |
Compositions and methods of muc13 antibodies for cancer treatment and diagnosis
|
|
US20160312207A1
(en)
|
2015-04-21 |
2016-10-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
R-spondin antagonists and methods of treating cancer associated with aberrant activation of wnt signaling
|
|
WO2016205566A1
(en)
|
2015-06-16 |
2016-12-22 |
The Regents Of The University Of California |
Fzd7 specific antibodies and vaccines to treat cancer and control stem cell function
|
|
US10766962B2
(en)
|
2015-06-16 |
2020-09-08 |
The Regents Of The University Of California |
FZD7 specific antibodies and vaccines to treat cancer and control stem cell function
|
|
EA039859B1
(ru)
|
2015-07-31 |
2022-03-21 |
Эмджен Рисерч (Мюник) Гмбх |
Биспецифические конструкты антител, связывающие egfrviii и cd3
|
|
US20190093072A1
(en)
|
2015-10-21 |
2019-03-28 |
Indiana University Research And Technology Corporation |
Methods of generating human inner ear sensory epithelia and sensory neurons
|
|
KR102802241B1
(ko)
|
2015-12-04 |
2025-05-07 |
베링거 인겔하임 인터내셔날 게엠베하 |
종양 세포에서 wnt 신호 전달을 길항하는 바이파라토픽 폴리펩타이드
|
|
US10919968B2
(en)
|
2016-01-29 |
2021-02-16 |
Modmab Therapeutics Corporation |
Frizzled5 protein-binding agents
|
|
CN116063544A
(zh)
|
2016-02-03 |
2023-05-05 |
安进研发（慕尼黑）股份有限公司 |
Bcma和cd3双特异性t细胞接合抗体构建体
|
|
RU2767329C2
(ru)
|
2016-02-06 |
2022-03-17 |
Эпимаб Биотерапьютикс, Инк. |
Иммуноглобулин с тандемными fab-фрагментами и варианты его применения
|
|
WO2017151907A1
(en)
|
2016-03-02 |
2017-09-08 |
Frequency Therapeutics, Inc. |
Methods for controlled proliferation of stem cells / generating inner ear hair cells using gsk-3-alpha inhibitors
|
|
WO2017152102A2
(en)
|
2016-03-04 |
2017-09-08 |
Alector Llc |
Anti-trem1 antibodies and methods of use thereof
|
|
US20170349659A1
(en)
|
2016-06-03 |
2017-12-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Wnt signaling agonist molecules
|
|
JP7617603B2
(ja)
|
2017-01-11 |
2025-01-20 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
Ｒ－スポンジン（ｒｓｐｏ）サロゲート分子
|
|
JP7305543B2
(ja)
|
2017-01-26 |
2023-07-10 |
スロゼン オペレーティング， インコーポレイテッド |
組織特異的Ｗｎｔシグナル増強分子およびその使用
|
|
PL3630816T3
(pl)
|
2017-05-31 |
2024-08-05 |
Boehringer Ingelheim International Gmbh |
Polipeptydy antagonizujące sygnalizację wnt w komórkach nowotworowych
|
|
KR102782136B1
(ko)
|
2017-11-08 |
2025-03-18 |
쿄와 기린 가부시키가이샤 |
CD40과 EpCAM에 결합하는 이중특이적 항체
|
|
EP3732201A4
(en)
|
2017-12-19 |
2022-04-20 |
Surrozen Operating, Inc. |
WNT SURROGATES AND THEIR USES
|
|
CN111655729B
(zh)
|
2017-12-19 |
2023-10-20 |
瑟罗泽恩奥普瑞汀公司 |
抗卷曲蛋白抗体和使用方法
|
|
CN111699003B
(zh)
|
2017-12-19 |
2024-05-03 |
瑟罗泽恩奥普瑞汀公司 |
抗lrp5/6抗体和使用方法
|
|
US20210032352A1
(en)
|
2018-02-14 |
2021-02-04 |
Antera Therapeutics Inc. |
Multivalent Binding Molecules Activating WNT Signaling and Uses Thereof
|
|
EP3768701B1
(en)
|
2018-03-23 |
2023-08-02 |
Université Libre de Bruxelles |
Wnt signaling agonist molecules
|
|
CA3104526A1
(en)
*
|
2018-07-05 |
2020-01-09 |
Surrozen, Inc. |
Multi-specific wnt surrogate molecules and uses thereof
|
|
JP2021530223A
(ja)
|
2018-07-09 |
2021-11-11 |
スロゼン， インコーポレイテッド |
組織特異性Ｗｎｔシグナル増強分子及びその使用
|
|
CA3106625A1
(en)
|
2018-07-16 |
2020-01-23 |
The Board Of Trustees Of The Leland Stanford Junior University |
Frizzled specific wnt agonists and antagonists
|
|
US20220064337A1
(en)
|
2018-12-19 |
2022-03-03 |
Surrozen, Inc. |
Antigen binding formats for receptor complexes
|
|
JP7663501B2
(ja)
|
2019-02-11 |
2025-04-16 |
スロゼン オペレーティング， インコーポレイテッド |
眼障害におけるｗｎｔシグナル伝達の調節
|
|
US20220195053A1
(en)
|
2019-03-11 |
2022-06-23 |
Surrozen Operating Inc. |
Modulation of wnt signaling in gastrointestinal disorders
|
|
US20220175884A1
(en)
|
2019-04-02 |
2022-06-09 |
Surrozen Operating, Inc. |
Modulation of wnt signaling in auditory disorders
|
|
US11050604B2
(en)
|
2019-07-01 |
2021-06-29 |
Rampart Communications, Inc. |
Systems, methods and apparatuses for modulation-agnostic unitary braid division multiplexing signal transformation
|
|
AU2020300618A1
(en)
|
2019-07-02 |
2022-01-27 |
Surrozen Operating, Inc. |
Monospecific anti-frizzled antibodies and methods of use
|
|
CN115427446A
(zh)
|
2020-02-24 |
2022-12-02 |
瑟罗泽恩奥普瑞汀公司 |
Wnt超级激动剂
|
|
US12606868B2
(en)
|
2020-02-24 |
2026-04-21 |
The Board Of Regents Of The University Of Texas System |
Molecular biomarkers and targets for Fuchs' endothelial corneal dystrophy and glaucoma
|
|
TW202233656A
(zh)
|
2020-11-16 |
2022-09-01 |
美商蘇羅森營運公司 |
肝特異性wnt訊號增強分子及其用途
|
|
WO2022130342A1
(en)
|
2020-12-18 |
2022-06-23 |
Antlera Therapeutics Inc. |
Tetravalent fzd and wnt co-receptor binding antibody molecules and uses thereof
|
|
JP2024509266A
(ja)
*
|
2021-03-10 |
2024-02-29 |
スロゼン オペレーティング， インコーポレイテッド |
胃腸障害におけるｗｎｔシグナル伝達のモジュレーション
|
|
AU2022313786B2
(en)
|
2021-07-20 |
2024-10-10 |
Boston Scientific Medical Device Limited |
Over the scope clip with repositional capability
|
|
WO2023044348A1
(en)
|
2021-09-14 |
2023-03-23 |
Surrozen Operating, Inc. |
Modulation of wnt signalling in pulmonary disorders
|
|
EP4448009A4
(en)
|
2021-12-17 |
2025-12-10 |
Surrozen Operating Inc |
WNT SUBSTITUTION AGENTS AND LACRYMAL GLAND REGENERATION METHODS
|
|
WO2023130055A2
(en)
|
2021-12-31 |
2023-07-06 |
Surrozen Operating, Inc. |
Wnt receptor-specific compound and method relating thereto
|
|
CN119403570A
(zh)
|
2022-06-21 |
2025-02-07 |
瑟罗泽恩奥普瑞汀公司 |
Wnt信号传导在角膜病中的调节作用
|
|
WO2024040118A2
(en)
|
2022-08-16 |
2024-02-22 |
Surrozen Operating, Inc. |
Cell targeting multicomponent polypeptide
|
|
US20240262918A1
(en)
|
2022-12-30 |
2024-08-08 |
Surrozen Operating, Inc. |
Fc-modified wnt surrogate molecules and uses thereof
|
|
AU2024279826A1
(en)
|
2023-05-29 |
2026-01-08 |
Surrozen Operating, Inc. |
Wnt surrogate agents and methods for lacrimal gland regeneration
|